Crystal Haskin-Cole, DPM
Foot Surgery · Warwick, NYNPI 1851687172
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,102 of the $3,663 with a category attached, or 84.7%. 20 manufacturers reported payments, led by Organogenesis Inc. at 24.6% of the total. Reporting peaked in 2021 at $1,291 and has fallen 71.9% since, to $363 in 2025.
Across 144 payments — averaging $25.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$900
- Treace Medical Concepts, Inc.$766
- Smith+Nephew$550
- Paratek Pharmaceuticals, Inc.$321
- KCI USA, Inc.$233
- Misonix Inc$188
- plus $705 from 14 others
What the payments were for
- Travel & lodging$56115%
- Food & beverage$3,10285%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 34 | $900 |
| Treace Medical Concepts, Inc. | 6 | $766 |
| Smith+Nephew | 37 | $550 |
| Paratek Pharmaceuticals, Inc. | 21 | $321 |
| KCI USA, Inc. | 3 | $233 |
| Misonix Inc | 5 | $188 |
| Advanced Oxygen Therapy Inc. | 11 | $178 |
| Bioventus LLC | 6 | $170 |
| Amgen | 8 | $107 |
| Kerecis Limited | 2 | $38 |
| DJO, LLC | 1 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Stryker | 1 | $33 |
| Sandoz | 1 | $20 |
| Medtronic | 1 | $19 |
| Mimedx Group, Inc. | 1 | $18 |
| Averitas Pharma Inc. | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $14 |
| Paragon 28, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$671
- V.A.C. DERMATAC$187
- V.A.C. VERAFLO$187
- Affinity$125
How this compares
$3,663 in reported general payments places this provider in the 85th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 58 | $5,822 |
| Ammonium Lactate | 62 | $1,423 |
| Doxycycline Hyclate | 93 | $980 |
| Mupirocin | 79 | $566 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $525 |
| Terbinafine Hcl | 23 | $191 |
| Methylprednisolone | 14 | $87 |
| Meloxicam | 40 | $48 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Warwick
- Ronald GubermanRidgewood$337K
- John JackaloneBethpage$66K
- David WongBronx$45K
- Berdj StepanianWhite Plains$26K
- Lawrence SantiBrooklyn$25K
- David GitlinBayside$24K
- Rick DelmonteNew York$21K
- Corrine RenneFranklin Square$20K
- Charles MorelliMamaroneck$18K
- Evan BrethBrooklyn$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.